Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Mise à jour : Il y a 4 ans
Référence : NCT01040741

Femme et Homme

Extrait

This is an observational safety study of a prophylactic use of Flu Egg Derived Adjuvanted Swine Origin A(H1N1) Vaccine in subjects 6 months of age and older. Subjects may receive either 1 or 2 doses: children and elderly will receive 2 doses and adults will receive either 1 or 2 doses.


Critère d'inclusion

  • Pandemic Influenza A (H1N1) ,A New Flu Virus of Swine Origin

Liens